The Prime Minister has stressed the UK’s border controls remain some of the toughest in the world – despite growing criticism over how a Brazilian COVID-19 variant of concern – made it to the UK. Boris Johnson has said there’s “no reason” to think vaccines won’t be effective against the variant. But, there are concerns that one…
CNN’s John King goes over the current coronavirus numbers from across the nation and takes a closer look at Covid-19 cases leveling off at numbers higher than health officials would like. #CNN #News
The Brazilian COVID-19 “variant of concern” – first detected in the city of Manaus – has been discovered in the UK. It comes after a new milestone was reached after it was confirmed more than 20 million people have now had their first dose of a coronavirus vaccine in the UK. SUBSCRIBE to our YouTube channel for more videos: http://www.youtube.com/skynews…
The announcement this week of the roadmap towards lifting the lockdown has coincided with an increase in people going to hospital, some with COVID-19 but many with more familiar winter complaints. Sky’s Health Correspondent Ashish Joshi visits Warrington Hospital, which has seen a sharp spike in emergency attendances. SUBSCRIBE to our YouTube channel for more videos: http://www.youtube.com/skynews Follow us…
Health Canada has approved use of the COVID-19 vaccine from AstraZeneca, clearing the way for millions of more inoculations in Canada. The country has secured access to 20 million doses of the vaccine. »»» Subscribe to CBC News to watch more videos: http://bit.ly/1RreYWS Connect with CBC News Online: For breaking news, video, audio and in-depth coverage: http://bit.ly/1Z0m6iX Find CBC News…
An FDA review released today confirms the single-dose Johnson & Johnson vaccine is both safe and effective against COVID-19, likely setting the stage for a third vaccine to be authorized for use in the U.S. Dr. Neeta Ogden joins CBSN with more. CBSN is CBS News’ 24/7 digital streaming news service featuring live, anchored coverage available for free across…
Answers to your coronavirus questions from Dr. Jen Ashton.
The FDA is reviewing the Johnson & Johnson COVID-19 vaccine and it could get emergency authorization by the end of the week. Unlike the Moderna and Pfizer vaccines, this one only requires only one shot. Josh Michaud, associate director for global health policy at the Kaiser Family Foundation, joins CBSN AM to discuss the significance.
The FDA is reviewing the Johnson & Johnson COVID-19 vaccine and it could get emergency authorization by the end of the week. Unlike the Moderna and Pfizer vaccines, this one only requires only one shot. Josh Michaud, associate director for global health policy at the Kaiser Family Foundation, joins CBSN AM to discuss the significance.
The FDA is reviewing the Johnson & Johnson COVID-19 vaccine and it could get emergency authorization by the end of the week. Unlike the Moderna and Pfizer vaccines, this one only requires only one shot. Josh Michaud, associate director for global health policy at the Kaiser Family Foundation, joins CBSN AM to discuss the significance.
